News -
With an approaching serialisation deadline, following the introduction of new legislation in the pharmaceuticals market to deal with the threat of counterfeit drugs, Clinical Trials Insight talks to Lars Højberg, life sciences expert at NNIT, about the best strategy for complying with serialisation.
To prevent counterfeit, regulation requiring serialization is enforced. But even serial numbers can be counterfeited, especially if batches have sequential codes. Enter the need to generate unique bar codes and serial numbers that are not computed algorithmically. Such capability also needs to operate globally to ensure compliance around the world. NNIT's SafeCoder does exactly this.